Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

The influence of depressive symptoms on quality of life after stroke: a prospective study.

Guajardo VD, Terroni L, Sobreiro Mde F, Zerbini MI, Tinone G, Scaff M, Iosifescu DV, de Lucia MC, Fráguas R.

J Stroke Cerebrovasc Dis. 2015 Jan;24(1):201-9. doi: 10.1016/j.jstrokecerebrovasdis.2014.08.020. Epub 2014 Nov 12.

PMID:
25440338
[PubMed - in process]
2.

Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial.

Murrough JW, Burdick KE, Levitch CF, Perez AM, Brallier JW, Chang LC, Foulkes A, Charney DS, Mathew SJ, Iosifescu DV.

Neuropsychopharmacology. 2014 Nov 6. doi: 10.1038/npp.2014.298. [Epub ahead of print]

PMID:
25374095
[PubMed - as supplied by publisher]
3.

Ketamine safety and tolerability in clinical trials for treatment-resistant depression.

Wan LB, Levitch CF, Perez AM, Brallier JW, Iosifescu DV, Chang LC, Foulkes A, Mathew SJ, Charney DS, Murrough JW.

J Clin Psychiatry. 2014 Sep 2. [Epub ahead of print]

PMID:
25271445
[PubMed - as supplied by publisher]
4.

The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorder.

Sylvia LG, Rabideau DJ, Nierenberg AA, Bowden CL, Friedman ES, Iosifescu DV, Thase ME, Ketter T, Greiter EA, Calabrese JR, Leon AC, Ostacher MJ, Reilly-Harrington N.

J Affect Disord. 2014 Dec 1;169:144-8. doi: 10.1016/j.jad.2014.08.019. Epub 2014 Aug 20.

PMID:
25194782
[PubMed - in process]
5.

Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression.

Treadway MT, Waskom ML, Dillon DG, Holmes AJ, Park MT, Chakravarty MM, Dutra SJ, Polli FE, Iosifescu DV, Fava M, Gabrieli JD, Pizzagalli DA.

Biol Psychiatry. 2015 Feb 1;77(3):285-94. doi: 10.1016/j.biopsych.2014.06.018. Epub 2014 Jul 3.

PMID:
25109665
[PubMed - in process]
6.

Dissociable cortico-striatal connectivity abnormalities in major depression in response to monetary gains and penalties.

Admon R, Nickerson LD, Dillon DG, Holmes AJ, Bogdan R, Kumar P, Dougherty DD, Iosifescu DV, Mischoulon D, Fava M, Pizzagalli DA.

Psychol Med. 2015 Jan;45(1):121-31. doi: 10.1017/S0033291714001123. Epub 2014 May 15.

PMID:
25055809
[PubMed - in process]
7.

Executive function and depressive symptoms of retardation in nonelderly stroke patients.

Sobreiro MF, Miotto EC, Terroni L, Tinone G, Iosifescu DV, de Lucia MC, Scaff M, Leite Cda C, Amaro E Jr, Fraguas R.

J Clin Exp Neuropsychol. 2014;36(6):636-47. doi: 10.1080/13803395.2014.925092.

PMID:
24974834
[PubMed - in process]
8.

Cognition, functional capacity, and self-reported disability in women with posttraumatic stress disorder: examining the convergence of performance-based measures and self-reports.

Kaye JL, Dunlop BW, Iosifescu DV, Mathew SJ, Kelley ME, Harvey PD.

J Psychiatr Res. 2014 Oct;57:51-7. doi: 10.1016/j.jpsychires.2014.06.002. Epub 2014 Jun 12.

PMID:
24974001
[PubMed - in process]
9.

Biomarkers in major depressive disorder: the role of mass spectrometry.

Woods AG, Iosifescu DV, Darie CC.

Adv Exp Med Biol. 2014;806:545-60. doi: 10.1007/978-3-319-06068-2_27. Review.

PMID:
24952202
[PubMed - indexed for MEDLINE]
10.

Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial.

Dunlop BW, Rothbaum BO, Binder EB, Duncan E, Harvey PD, Jovanovic T, Kelley ME, Kinkead B, Kutner M, Iosifescu DV, Mathew SJ, Neylan TC, Kilts CD, Nemeroff CB, Mayberg HS.

Trials. 2014 Jun 21;15:240. doi: 10.1186/1745-6215-15-240.

PMID:
24950747
[PubMed - in process]
Free PMC Article
11.

A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial.

Rabideau DJ, Nierenberg AA, Sylvia LG, Friedman ES, Bowden CL, Thase ME, Ketter TA, Ostacher MJ, Reilly-Harrington N, Iosifescu DV, Calabrese JR, Leon AC, Schoenfeld DA.

Clin Trials. 2014 May 28;11(4):494-502. [Epub ahead of print]

PMID:
24872362
[PubMed - as supplied by publisher]
12.

A randomized controlled trial of intranasal ketamine in major depressive disorder.

Lapidus KA, Levitch CF, Perez AM, Brallier JW, Parides MK, Soleimani L, Feder A, Iosifescu DV, Charney DS, Murrough JW.

Biol Psychiatry. 2014 Dec 15;76(12):970-6. doi: 10.1016/j.biopsych.2014.03.026. Epub 2014 Apr 3.

PMID:
24821196
[PubMed - in process]
13.

Cognitive-emotional training as an intervention for major depressive disorder.

Iacoviello BM, Wu G, Alvarez E, Huryk K, Collins KA, Murrough JW, Iosifescu DV, Charney DS.

Depress Anxiety. 2014 Aug;31(8):699-706. doi: 10.1002/da.22266. Epub 2014 Apr 17.

PMID:
24753225
[PubMed - in process]
14.

Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression.

Price RB, Iosifescu DV, Murrough JW, Chang LC, Al Jurdi RK, Iqbal SZ, Soleimani L, Charney DS, Foulkes AL, Mathew SJ.

Depress Anxiety. 2014 Apr;31(4):335-43. doi: 10.1002/da.22253. Epub 2014 Mar 25.

PMID:
24668760
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Rare copy number variation in treatment-resistant major depressive disorder.

O'Dushlaine C, Ripke S, Ruderfer DM, Hamilton SP, Fava M, Iosifescu DV, Kohane IS, Churchill SE, Castro VM, Clements CC, Blumenthal SR, Murphy SN, Smoller JW, Perlis RH.

Biol Psychiatry. 2014 Oct 1;76(7):536-41. doi: 10.1016/j.biopsych.2013.10.028. Epub 2014 Jan 19.

PMID:
24529801
[PubMed - in process]
Free PMC Article
16.

Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association.

Ostacher MJ, Iosifescu DV, Hay A, Blumenthal SR, Sklar P, Perlis RH.

Bipolar Disord. 2014 Mar;16(2):199-203. doi: 10.1111/bdi.12143. Epub 2013 Dec 27.

PMID:
24372835
[PubMed - indexed for MEDLINE]
17.

Medication adherence in a comparative effectiveness trial for bipolar disorder.

Sylvia LG, Reilly-Harrington NA, Leon AC, Kansky CI, Calabrese JR, Bowden CL, Ketter TA, Friedman ES, Iosifescu DV, Thase ME, Ostacher MJ, Keyes M, Rabideau D, Nierenberg AA.

Acta Psychiatr Scand. 2014 May;129(5):359-65. doi: 10.1111/acps.12202. Epub 2013 Oct 3.

PMID:
24117232
[PubMed - indexed for MEDLINE]
18.

Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression.

Haile CN, Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Foulkes A, Iqbal S, Mahoney JJ 3rd, De La Garza R 2nd, Charney DS, Newton TF, Mathew SJ.

Int J Neuropsychopharmacol. 2014 Feb;17(2):331-6. doi: 10.1017/S1461145713001119. Epub 2013 Oct 8.

PMID:
24103211
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response.

Murrough JW, Wan LB, Iacoviello B, Collins KA, Solon C, Glicksberg B, Perez AM, Mathew SJ, Charney DS, Iosifescu DV, Burdick KE.

Psychopharmacology (Berl). 2013 Sep 11. [Epub ahead of print]

PMID:
24022236
[PubMed - as supplied by publisher]
20.

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.

Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, Iqbal S, Pillemer S, Foulkes A, Shah A, Charney DS, Mathew SJ.

Am J Psychiatry. 2013 Oct;170(10):1134-42. doi: 10.1176/appi.ajp.2013.13030392.

PMID:
23982301
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk